NONCLINICAL STUDIES SUBCOMMITTEE

GUEST PARTICIPANTS FOR NOVEMBER 13, 2001 MEETING:

NCTR COMMITTEE REPRESENTATIVE:

Kenneth R. Tindall, Ph.D.

North Carolina Biotechnology Center

15 T. W. Alexander Dr.

P.O. Box 13547

Research Triangle Park, NC 27709-3547

 

NCSS ACADEMIC PARTICIPANTS:

Kendall B. Wallace, Ph.D., D.A.B.T.

Professor, Department of Biochemistry

& Molecular Biology

University of Minnesota

School of Medicine

Duluth, MN 55812-2487

INVITED INDUSTRY PARTICIPANTS:

Gordon Holt, Ph.D.

Principal Scientist

Oxford GlycoSciences

4 Sparrow Valley CT

Montgomery Village MD 20886-1265

 

Lester W. Schwartz, DVM, Ph.D.

Group Director, Clinical, Cellular

and Biochemical Pathology

SmithKline Beecham Pharmaceuticals

Safety Assessment US

709 Swedeland Road, UE0360

King of Prussia, PA 19406-2799

 

William D. Kerns DVM, MS, DACVP

Pharma Consulting Inc.

PO Box 322

112 Bolton Road

Harvard, MA 01451

GOVERNMENT PARTICIPANTS:

Thomas Papoian, Ph.D.

FDA/CDER/ORM/ DACADP, HFD-170

Parklawn Bldg 9B-45

5600 Fishers Lane

Rockville, MD 20857

 

Elizabeth A. Hausner, D.V.M., D.A.V.T.

FDA/CDER/ORM/DCRDP/HFD-110

WOC 2 Building, Room 5060

1451 Rockville Pike

Rockville, MD 20852